Cite
HARVARD Citation
Cui, W. et al. (n.d.). Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: results from the VISION study and local UK experience. Lung cancer. pp. S38-S39. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cui, W. et al. (n.d.). Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: results from the VISION study and local UK experience. Lung cancer. pp. S38-S39. [Online].